Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microparticles in Autoimmunity: Cause or Consequence of Disease? | Front Immunol | 2022 | 35514984 | PubTator, text mining | PubMed |
| Zika virus impacts extracellular vesicle composition and cellular gene expression in macaque early gestation trophoblasts. | Sci Rep | 2022 | 35513694 | PubTator, text mining | PubMed |
| ISG20 inhibits bluetongue virus replication. | Virol Sin | 2022 | 35513266 | PubTator, text mining | PubMed |
| First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response. | Clin Cancer Res | 2022 | 35511938 | PubTator, text mining | PubMed |
| Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond. | Ther Adv Hematol | 2022 | 35510210 | PubTator, text mining | PubMed |
| Significance of T-Cell Subsets for Clinical Response to Peginterferon Alfa-2a Therapy in HBeAg-Positive Chronic Hepatitis B Patients. | Int J Gen Med | 2022 | 35509606 | PubTator, text mining | PubMed |
| Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes. | Cancer Immunol Res | 2022 | 35507919 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19. | Genome Med | 2022 | 35501841 | PubTator, text mining | PubMed |
| COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. | Blood Adv | 2022 | 35500220 | PubTator, text mining | PubMed |
| Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis. | J Immunol Res | 2022 | 35497880 | PubTator, text mining | PubMed |
| Tumor-infiltrating ICOS+ Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' Tumor. | Anticancer Res | 2022 | 35489733 | PubTator, text mining | PubMed |
| Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients. | Asian Pac J Cancer Prev | 2022 | 35485701 | PubTator, text mining | PubMed |
| Contact-Dependent Granzyme B-Mediated Cytotoxicity of Th17-Polarized Cells Toward Human Oligodendrocytes. | Front Immunol | 2022 | 35479072 | PubTator, text mining | PubMed |
| Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2. | Emerg Microbes Infect | 2022 | 35476817 | PubTator, text mining | PubMed |
| Differential gene expression in nasal airway epithelium from overweight or obese youth with asthma. | Pediatr Allergy Immunol | 2022 | 35470932 | PubTator, text mining | PubMed |
Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution. | Hematol Rep | 2022 | 35466184 | PubTator, text mining | PubMed |
| Deconvolution of Adult T-Cell Leukemia/Lymphoma With Single-Cell RNA-Seq Using Frozen Archived Skin Tissue Reveals New Subset of Cancer-Associated Fibroblast. | Front Immunol | 2022 | 35464471 | PubTator, text mining | PubMed |
| Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19. | Front Immunol | 2022 | 35464396 | PubTator, text mining | PubMed |
| SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies. | Signal Transduct Target Ther | 2022 | 35461307 | PubTator, text mining | PubMed |
| Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution. | Cancers (Basel) | 2022 | 35454904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=50